Viatris Unit Can't Ax Patent For Anemia Drug Evrenzo
Viatris, Teva and Sandoz have lost their challenge to a rival's European patent for anemia drug Evrenzo, failing to convince an appeals panel that the treatment is not inventive enough to...To view the full article, register now.
Already a subscriber? Click here to view full article